Differences between endocrine surgeons and endocrinologists in the management of non-toxic multinodular goitre

British Journal of Surgery

Volumn 90, Issue 9, 2003, Pages 1103-1112

  Bhagat, M C ^a   Dhaliwal, S S ^a   Bonnema, S J ^b   Hegedus L ^b   Walsh, J P ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; TECHNETIUM 99M; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ARTICLE; ASPIRATION BIOPSY; AUSTRALIA; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; EUTHYROIDISM; HUMAN; MEDICAL SPECIALIST; NODULAR GOITER; NORMAL HUMAN; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSTERNAL GOITER; SCINTIGRAPHY; SURGEON; THYROID SURGERY; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; AUSTRALIA; BIOPSY, NEEDLE; CANADA; ENDOCRINOLOGY; EUROPE; FEMALE; GOITER, NODULAR; HUMANS; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; PROFESSIONAL PRACTICE; QUESTIONNAIRES; REFERRAL AND CONSULTATION; UNITED STATES;

EID: 0141518215     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4171     Document Type: Article

References (32)

1. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997; 26: 189-218.
2. Hegedüs L, Bonnema SJ, Bennedbæk FN. Management of simple and nodular goiter: current status and future perspectives. Endocr Rev 2003; 24: 102-132.
3. Henneman G. Multinodular goiter. In Thyroid Disease Manager, DeGroot LJ, Henneman G (eds). http://www.thyroidmanager.org/chapter17/17-frame.htm [23 October 2002].
4. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998; 128: 386-394.
5. Hermus AR, Huysmans DA. Treatment of benign nodular thyroid disease. N Engl J Med 1998; 338: 1438-1447.
6. Franklyn JA. Lack of consensus in Europe in the management of nontoxic multinodular goitre. Clin Endocrinol (Oxf) 2000; 53: 3-4.
7. Nygaard B, Hegedüs L, Ulriksen P, Nielsen KG, Hansen JM. Radioiodine therapy for multinodular toxic goiter. Arch Intern Med 1999; 159: 1364-1368.
8. Wesche MFT, Tiel-Buul MMC, Lips P, Smits NJ, Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001; 86: 998-1005.
9. Bonnema SJ, Bennedbæk FN, Wiersinga WM, Hegedüs L. Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol (Oxf) 2000; 53: 5-12.
10. Bonnema SJ, Bennedbæk FN, Ladenson PVV, Hegedüs L. Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 2002; 87: 112-117.
11. Dent O. Clinical Workforce Surveys 2001. Royal Australasian College of Physicians: Sydney, 2001.
12. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 1994; 78: 826-829.
13. Rieu M, Lame M-C, Richard A, Lissak B, Sambort B, Vuong-Ngoc P et al. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf) 1995; 42: 453-460.
14. Niccoli P, Wion-Barbot N, Caron P, Henry J-F, De Micco C, Saint Andre J-P et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 1997; 82: 338-341.
15. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B. Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 1997; 82: 1589-1593.
16. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001; 11: 73-80.
17. Horvit PK, Gagel RF. The goitrous patient with an elevated serum calcitonin - what to do? J Clin Endocrinol Metab 1997; 82: 335-337.
18. Wong CKM, Wheeler MH. Thyroid nodules: rational management. World J Surg 2000; 24: 934-941.
19. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000; 133: 696-700.
20. Rojeski MT, Gharib H. Nodular thyroid disease. Evaluation and management. N Engl J Med 1985; 313: 428-436.
21. Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR. Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 1989; 106: 980-985.
22. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553-559.
23. Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996; 156: 2165-2172.
24. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-1252.
25. Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal integrity. Ann Intern Med 1999; 130: 750-758.
26. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001; 134: 561-568.
27. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001; 358: 861-865.
28. Bonnema SJ, Knudsen DU, Bertelsen H, Mortensen J, Andersen PB, Bastholt L et al. Does radioiodine therapy have an equal effect on substernal and cervical goiter volumes? Evaluation by magnetic resonance imaging. Thyroid 2002; 12: 313-317.
29. Kaplan EL, Sugg SL. Surgery of the thyroid. In Endocrinology (4th edn), DeGroot L, Jameson JL (eds). WB Saunders: Philadelphia, 2001; 1567-1585.
30. Delbridge L, Guinea AI, Reeve TS. Total thyroidectomy for bilateral benign multinodular goiter: effect of changing practice. Arch Surg 1999; 134: 1389-1393.
31. Wheeler MH. Total thyroidectomy for benign thyroid disease. Lancet 1998; 351: 1526-1527.
32. Gough IR, Wilkinson D. Total thyroidectomy for management of thyroid disease. World J Surg 2000; 24: 962-965.